PMDA drug package insert
デュロキセチン錠20mg「ケミファ」
PMDA Prescription drug · 富士化学工業株式会社 · package insert Sep 22, 2022
Key facts
| Brand names | デュロキセチン錠20mg「ケミファ」, デュロキセチン錠30mg「ケミファ」 |
|---|---|
| Nonproprietary names | デュロキセチン塩酸塩 |
| Companies | 製造販売元／富士化学工業株式会社, 販売元／日本ケミファ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | セロトニン・ノルアドレナリン再取り込み阻害剤 |
| Therapeutic category codes | 871179, 87119 |
| YJ codes | 1179052F1023, 1179052F2020 |
| Approval numbers | 30300AMX00178000, 30300AMX00176000 |
| Package insert edition | 第3版 |
| Package insert date | Sep 22, 2022 |
| PMDA document key | 670082_1179052F1023_1 |
| PMDA company code | 670082 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: